EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.2.1.133 | Carcinoma |
18774480 |
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: A randomized Phase III clinical trial Ravaud A, Hawkins R, Gardner JP, von der Maase H, Zantl N, Harper P, Rolland F, Audhuy B, Machiels JP, Pétavy F, Gore M, Schöffski P, El-Hariry I, Department of Medical Oncology, Hôpital Saint André, Bordeaux, France. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
1
3
0 |
| 3.2.1.133 | Carcinoma, Renal Cell |
18774480 |
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: A randomized Phase III clinical trial Ravaud A, Hawkins R, Gardner JP, von der Maase H, Zantl N, Harper P, Rolland F, Audhuy B, Machiels JP, Pétavy F, Gore M, Schöffski P, El-Hariry I, Department of Medical Oncology, Hôpital Saint André, Bordeaux, France. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
1
3
0 |
| 3.2.1.133 | Hyperglycemia |
12723600 |
Acarviosine-simmondsin, a novel compound obtained from acarviosine-glucose and simmondsin by Thermus maltogenic amylase and its in vivo effect on food intake and hyperglycemia. |
ongoing research
unassigned |
3
0 |
| 3.2.1.133 | Neoplasms |
22398155 |
Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT. |
unassigned |
0 |
| 3.2.1.133 | Neoplasms |
28864844 |
Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer. |
therapeutic application
unassigned |
1
0 |
| 3.2.1.133 | Seminoma |
16520289 |
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP, MRC TE19 Collaborators and the EORTC 30982 Collaborators, Department of Medical Oncology, St. Bart's and the London Hospital, London, United Kingdom. |
therapeutic application
unassigned |
2
0 |
| 3.2.1.133 | Urinary Bladder Neoplasms |
28864844 |
Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer. |
therapeutic application
unassigned |
1
0 |
